Skip to content

Clinical trials

Phase 1 Carcinoma, Non-Small-Cell Lung trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1 Country / region: Hong Kong Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20141
20151
20172
20182
20193
20211
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting5
Completed5
Terminated3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Boehringer Ingelheim2
Amgen1
Boston Pharmaceuticals1
Hoffmann-La Roche1
MacroGenics1
Merck Sharp & Dohme LLC1
Olema Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung14
Neoplasms4
Colorectal Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Triple Negative Breast Neoplasms3
Melanoma2
Nasopharyngeal Carcinoma2
Ovarian Neoplasms2
Adenocarcinoma, Clear Cell1
Anus Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.